NO329385B1 - Fremgangsmate for opparbeidelse av celler - Google Patents
Fremgangsmate for opparbeidelse av celler Download PDFInfo
- Publication number
- NO329385B1 NO329385B1 NO20003215A NO20003215A NO329385B1 NO 329385 B1 NO329385 B1 NO 329385B1 NO 20003215 A NO20003215 A NO 20003215A NO 20003215 A NO20003215 A NO 20003215A NO 329385 B1 NO329385 B1 NO 329385B1
- Authority
- NO
- Norway
- Prior art keywords
- cells
- production
- production batch
- bioreactor
- batch
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims abstract description 69
- 239000000758 substrate Substances 0.000 claims description 16
- 239000012620 biological material Substances 0.000 claims description 14
- 230000001419 dependent effect Effects 0.000 claims description 11
- 238000012546 transfer Methods 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 8
- 241000700605 Viruses Species 0.000 claims description 6
- 229960000074 biopharmaceutical Drugs 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 129
- 238000000855 fermentation Methods 0.000 description 24
- 230000004151 fermentation Effects 0.000 description 24
- 239000000969 carrier Substances 0.000 description 10
- 239000001963 growth medium Substances 0.000 description 9
- 238000013341 scale-up Methods 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 238000013411 master cell bank Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241000466177 Cansumys canus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000353621 Eilat virus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000002338 cryopreservative effect Effects 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 229940124642 endogenous agent Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000013190 sterility testing Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Sustainable Development (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97204110 | 1997-12-24 | ||
| PCT/EP1998/008522 WO1999033955A1 (en) | 1997-12-24 | 1998-12-17 | Preparation of cells for production of biologicals |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20003215L NO20003215L (no) | 2000-06-21 |
| NO20003215D0 NO20003215D0 (no) | 2000-06-21 |
| NO329385B1 true NO329385B1 (no) | 2010-10-11 |
Family
ID=8229133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003215A NO329385B1 (no) | 1997-12-24 | 2000-06-21 | Fremgangsmate for opparbeidelse av celler |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20070148753A1 (cs) |
| EP (2) | EP1801201B1 (cs) |
| JP (1) | JP4478328B2 (cs) |
| KR (1) | KR100683429B1 (cs) |
| CN (1) | CN1185339C (cs) |
| AT (2) | ATE356197T1 (cs) |
| AU (1) | AU758209B2 (cs) |
| BR (1) | BR9814490A (cs) |
| CA (1) | CA2316739C (cs) |
| CZ (1) | CZ299719B6 (cs) |
| DE (2) | DE69842245D1 (cs) |
| DK (2) | DK1801201T3 (cs) |
| ES (2) | ES2281148T5 (cs) |
| HU (1) | HUP0100538A3 (cs) |
| ID (1) | ID26784A (cs) |
| IL (1) | IL136736A (cs) |
| NO (1) | NO329385B1 (cs) |
| NZ (1) | NZ505371A (cs) |
| PL (1) | PL196042B1 (cs) |
| PT (2) | PT1801201E (cs) |
| RU (1) | RU2230784C2 (cs) |
| SK (1) | SK285971B6 (cs) |
| TR (1) | TR200001960T2 (cs) |
| UA (1) | UA72732C2 (cs) |
| WO (1) | WO1999033955A1 (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010334723C1 (en) | 2009-12-23 | 2015-05-28 | Sanofi Pasteur | Method for culturing adherent cells |
| EP3737750B1 (en) | 2018-01-09 | 2024-06-05 | Theriva Biologics, Inc. | Alkaline phosphatase agents for treatment of neurodevelopmental disorders |
| EP4275761A3 (en) | 2018-03-20 | 2024-02-28 | Theriva Biologics, Inc. | Alkaline phosphatase agents for treatment of radiation disorders |
| US11638699B2 (en) | 2018-03-20 | 2023-05-02 | Theriva Biologics, Inc. | Intestinal alkaline phosphatase formulations |
| US12071607B2 (en) * | 2018-06-01 | 2024-08-27 | Lonza Ltd. | Midscale model for organic growth and phasing |
| KR20220005560A (ko) | 2019-05-06 | 2022-01-13 | 신세틱 바이오로직스, 인코퍼레이티드 | 알칼리성 포스페이트-기반 종양학 치료제 |
| EP4008774A4 (en) * | 2019-07-16 | 2023-09-27 | Innovent Biologics (Suzhou) Co., Ltd. | CELL CULTURE METHOD AND ITS APPLICATION BASED ON CONTINUOUS AND HIGH DENSITY INOCULATION |
| EP4339274B1 (en) | 2022-09-13 | 2025-03-26 | Sartorius Stedim Biotech GmbH | Method for operating a bioprocess installation for production of a bioproduct |
| CN116064409A (zh) * | 2023-01-06 | 2023-05-05 | 四川阿思科力生物科技有限公司 | 一种大规模高产量细胞连续培养和收获的生产工艺 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60151458A (ja) | 1984-01-20 | 1985-08-09 | Nippon Piston Ring Co Ltd | カムシヤフト |
| US4664912A (en) * | 1984-10-01 | 1987-05-12 | Wiktor Tadeusz J | Process for the large scale production of rabies vaccine |
| DE3833925A1 (de) * | 1988-03-11 | 1989-09-21 | Inst Angewandte Biotechnologie | Verfahren und herstellung von virus und viralem antigen und vorrichtung hierzu |
| US5017490A (en) | 1989-03-10 | 1991-05-21 | Baxter International Inc. | Method for in vitro reproduction and growth of cells in culture medium |
| DE3930140A1 (de) * | 1989-09-09 | 1991-03-21 | Bayer Ag | Verfahren zur herstellung von biologischen materialien in zellkulturen und vorrichtungen |
| WO1992010564A1 (en) * | 1990-12-13 | 1992-06-25 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
| DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| KR100787425B1 (ko) * | 2004-11-29 | 2007-12-26 | 삼성에스디아이 주식회사 | 페닐카바졸계 화합물 및 이를 이용한 유기 전계 발광 소자 |
| KR100669716B1 (ko) * | 2004-07-14 | 2007-01-16 | 삼성에스디아이 주식회사 | 페닐카르바졸 화합물 및 이를 이용한 유기 전계 발광 소자 |
| US8188315B2 (en) * | 2004-04-02 | 2012-05-29 | Samsung Mobile Display Co., Ltd. | Organic light emitting device and flat panel display device comprising the same |
| KR100573137B1 (ko) * | 2004-04-02 | 2006-04-24 | 삼성에스디아이 주식회사 | 플루오렌계 화합물 및 이를 이용한 유기 전계 발광 소자 |
| JP4184332B2 (ja) * | 2004-11-22 | 2008-11-19 | 本田技研工業株式会社 | 可変気筒式内燃機関の制御装置 |
-
1998
- 1998-12-17 AT AT98966693T patent/ATE356197T1/de active
- 1998-12-17 CA CA2316739A patent/CA2316739C/en not_active Expired - Fee Related
- 1998-12-17 NZ NZ505371A patent/NZ505371A/en not_active IP Right Cessation
- 1998-12-17 JP JP2000526613A patent/JP4478328B2/ja not_active Expired - Fee Related
- 1998-12-17 AU AU24179/99A patent/AU758209B2/en not_active Ceased
- 1998-12-17 SK SK965-2000A patent/SK285971B6/sk not_active IP Right Cessation
- 1998-12-17 EP EP07103139A patent/EP1801201B1/en not_active Expired - Lifetime
- 1998-12-17 TR TR2000/01960T patent/TR200001960T2/xx unknown
- 1998-12-17 PT PT07103139T patent/PT1801201E/pt unknown
- 1998-12-17 PL PL98341401A patent/PL196042B1/pl not_active IP Right Cessation
- 1998-12-17 DK DK07103139.7T patent/DK1801201T3/da active
- 1998-12-17 ES ES98966693T patent/ES2281148T5/es not_active Expired - Lifetime
- 1998-12-17 UA UA2000074455A patent/UA72732C2/uk unknown
- 1998-12-17 WO PCT/EP1998/008522 patent/WO1999033955A1/en active IP Right Grant
- 1998-12-17 CZ CZ20002343A patent/CZ299719B6/cs not_active IP Right Cessation
- 1998-12-17 ID IDW20001431A patent/ID26784A/id unknown
- 1998-12-17 CN CNB988126354A patent/CN1185339C/zh not_active Expired - Fee Related
- 1998-12-17 HU HU0100538A patent/HUP0100538A3/hu not_active Application Discontinuation
- 1998-12-17 IL IL13673698A patent/IL136736A/en not_active IP Right Cessation
- 1998-12-17 DE DE69842245T patent/DE69842245D1/de not_active Expired - Lifetime
- 1998-12-17 EP EP98966693A patent/EP1060241B2/en not_active Expired - Lifetime
- 1998-12-17 DK DK98966693.8T patent/DK1060241T4/da active
- 1998-12-17 BR BR9814490-1A patent/BR9814490A/pt not_active IP Right Cessation
- 1998-12-17 AT AT07103139T patent/ATE507284T1/de active
- 1998-12-17 ES ES07103139T patent/ES2365631T3/es not_active Expired - Lifetime
- 1998-12-17 KR KR1020007007068A patent/KR100683429B1/ko not_active Expired - Fee Related
- 1998-12-17 RU RU2000119783/13A patent/RU2230784C2/ru not_active IP Right Cessation
- 1998-12-17 PT PT98966693T patent/PT1060241E/pt unknown
- 1998-12-17 DE DE69837287T patent/DE69837287T3/de not_active Expired - Lifetime
-
2000
- 2000-06-21 NO NO20003215A patent/NO329385B1/no not_active IP Right Cessation
-
2007
- 2007-01-18 US US11/654,556 patent/US20070148753A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schimmer | [52] Adrenocortical Y1 cells | |
| US20070148753A1 (en) | Preparation of cells for production of biologicals | |
| CN1970080A (zh) | 用悬浮的Vero细胞生产病毒疫苗的方法 | |
| JP2003506077A (ja) | 組換え安定細胞クローン、その産生およびその使用 | |
| Bhatia et al. | Introduction to animal tissue culture science | |
| CN116948975A (zh) | Ifnar1基因敲除的mdck细胞株及其构建方法和应用 | |
| CN116496992A (zh) | 一种鸡胚成肌永生化细胞及其构建方法和应用 | |
| CN106967686B (zh) | 软骨细胞体外端粒延长增殖培养的方法及人源组织工程化再生软骨 | |
| Shapiro et al. | Growth of Heliothis zea (Lepidoptera: Noctuidae) cells adapted to various culture media | |
| HK1030628B (en) | Preparation of cells for production of biologicals | |
| HK1030628C (en) | Preparation of cells for production of biologicals | |
| CN109517800A (zh) | 一株补强胆固醇内源性合成的重构st细胞及其构建方法和用途 | |
| MXPA00006339A (en) | Preparation of cells for production of biologicals | |
| CN119979447A (zh) | 一种黄颡鱼胚胎细胞系及其传代培养方法和应用 | |
| JP6097725B2 (ja) | 組換え安定細胞クローン、その産生およびその使用 | |
| JP2011004754A (ja) | 組換え安定細胞クローン、その産生およびその使用 | |
| NO751303L (cs) | ||
| JP2010099093A (ja) | 組換え安定細胞クローン、その産生およびその使用 | |
| CN102776149A (zh) | 昆虫细胞系的建立方法 | |
| TW200540271A (en) | A method for cultivating primordial germ cells of fowl, a method for preparing the culture medium and products thereof | |
| JP2016178932A (ja) | 組換え安定細胞クローン、その産生およびその使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: ABBOTT BIOLOGICALS BV, NL |
|
| MM1K | Lapsed by not paying the annual fees |